Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-15 Sale | 2026-06-17 5:25 pm | Pelthos Therapeutics Inc. | PTHS | Friedberg Ezra M Director | 283 | $27.29 | $7,724 | 203,672 (Indirect Direct) | View |
| 2026-06-11 Purchase | 2026-06-15 5:25 pm | Pelthos Therapeutics Inc. | PTHS | Davis Todd C Director | 35,948 | $27.82 | $999,983 | 1,575,834 (Indirect Direct) | View |
| 2026-05-22 Sale | 2026-05-26 7:17 pm | Pelthos Therapeutics Inc. | PTHS | Francis Knuettel II CFO, Treas & Secty | 15,447 | $2.6067 | $40,265 | 100,341 (Indirect Direct) | View |
| 2026-04-02 Sale | 2026-04-06 5:03 pm | Pelthos Therapeutics Inc. | PTHS | Malamut Richard Director | 590 | $20.92 | $12,340 | 28,462 (Indirect Direct) | View |
| 2026-04-02 Sale | 2026-04-06 5:03 pm | Pelthos Therapeutics Inc. | PTHS | Friedberg Ezra M Director | 558 | $20.92 | $11,671 | 204,099 (Indirect Direct) | View |
| 2026-04-02 Sale | 2026-04-06 5:02 pm | Pelthos Therapeutics Inc. | PTHS | Pauls Matthew Director | 786 | $20.92 | $16,439 | 15,150 (Direct) | View |
| 2026-04-02 Sale | 2026-04-06 5:01 pm | Pelthos Therapeutics Inc. | PTHS | Greenleaf Peter Director | 797 | $20.92 | $16,670 | 24,681 (Direct) | View |
| 2025-11-25 Sale | 2025-11-26 12:37 pm | Pelthos Therapeutics Inc. | PTHS | Friedberg Ezra M Director | 10,000 | $28.03 | $280,281 | 124,573 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-05-22 Option Award | 2026-05-26 7:17 pm | 2026-05-22 2035-07-02 | Pelthos Therapeutics Inc. | PTHS | Francis Knuettel II CFO, Treas & Secty | 59,500 | $0 | 100,341 (Direct) | View |
| 2026-05-14 Tax Withholding | 2026-05-18 6:11 pm | N/A N/A | Pelthos Therapeutics Inc. | PTHS | Friedberg Ezra M Director | 144 | $27.01 | 203,955 (Direct) | View |
Ownership | 2026-04-20 5:00 pm | N/A N/A | Pelthos Therapeutics Inc. | PTHS | GAY JOHN M. Chief Financial Officer | 0 | $0 | 123,518 (Direct) | View |
| 2024-06-14 Option Award(A) | 2026-04-01 5:45 pm | N/A N/A | Pelthos Therapeutics Inc. | PTHS | Friedberg Ezra M Director | 28,012 | $0 | 204,657 (Direct) | View |
| 2024-06-14 Option Award(A) | 2026-04-01 5:45 pm | N/A N/A | Pelthos Therapeutics Inc. | PTHS | Davis Todd C Director | 36,969 | $0 | 1,539,886 (Direct) | View |
| 2024-06-14 Option Award(A) | 2026-04-01 5:44 pm | N/A N/A | Pelthos Therapeutics Inc. | PTHS | Malamut Richard Director | 28,012 | $0 | 29,052 (Direct) | View |
| 2025-07-02 Option Award(A) | 2026-04-01 5:44 pm | N/A N/A | Pelthos Therapeutics Inc. | PTHS | Plesha Scott M. CEO and President | 83,678 | $0 | 83,678 (Direct) | View |
| 2025-07-02 Option Award(A) | 2026-04-01 5:43 pm | N/A N/A | Pelthos Therapeutics Inc. | PTHS | Greenleaf Peter Director | 25,478 | $0 | 25,478 (Direct) | View |
| 2025-07-02 Option Award(A) | 2026-04-01 5:42 pm | N/A N/A | Pelthos Therapeutics Inc. | PTHS | Pauls Matthew Director | 25,478 | $0 | 25,478 (Direct) | View |
| 2025-07-02 Option Award(A) | 2026-04-01 5:42 pm | N/A N/A | Pelthos Therapeutics Inc. | PTHS | Rangarao Sai Chief Commercial Officer | 30,518 | $0 | 30,518 (Direct) | View |
| 2025-07-02 Option Award(A) | 2026-04-01 5:42 pm | N/A N/A | Pelthos Therapeutics Inc. | PTHS | Baxter Richard B Director | 19,108 | $0 | 19,108 (Direct) | View |
| 2025-07-02 Option Award(A) | 2026-04-01 5:39 pm | N/A N/A | Pelthos Therapeutics Inc. | PTHS | Francis Knuettel II CFO, Treas & Secty | 33,472 | $0 | 56,288 (Direct) | View |
| 2025-12-23 Option Award | 2025-12-29 4:16 pm | N/A N/A | Pelthos Therapeutics Inc. | PTHS | Einhorn Andrew J. Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2025-12-17 Option Award | 2025-12-19 4:15 pm | 2025-11-06 2027-11-06 | Pelthos Therapeutics Inc. | PTHS | LIGAND PHARMACEUTICALS INC Director 10% Owner | 9,000,000 | $0 | 9,000,000 (Direct) | View |
| 2025-07-02 Exercise | 2025-12-12 5:01 pm | N/A N/A | Pelthos Therapeutics Inc. | PTHS | Pauls Matthew Director | 10,616 | $0 | 32,921 (Direct) | View |
| 2025-12-10 Gift | 2025-12-12 5:01 pm | N/A N/A | Pelthos Therapeutics Inc. | PTHS | Pauls Matthew Director | 9,542 | $0 | 32,921 (Direct) | View |
| 2025-11-06 Option Award | 2025-11-10 4:43 pm | N/A N/A | Pelthos Therapeutics Inc. | PTHS | LIGAND PHARMACEUTICALS INC Director 10% Owner | 9,000,000 | $9,000,000 | 9,000,000 (Direct) | View |
| 2025-07-02 Option Award | 2025-07-23 9:17 pm | 2026-07-02 2035-07-02 | Pelthos Therapeutics Inc. | PTHS | Plesha Scott M. CEO and President | 338,678 | $0 | 338,678 (Direct) | View |
| 2025-07-02 Option Award | 2025-07-21 8:26 pm | 2026-07-02 2035-07-02 | Pelthos Therapeutics Inc. | PTHS | Rangarao Sai Chief Commercial Officer | 123,518 | $0 | 123,518 (Direct) | View |
| 2025-07-02 Option Award | 2025-07-07 9:47 pm | 2026-07-02 2035-07-02 | Pelthos Therapeutics Inc. | PTHS | Baxter Richard B Director | 77,338 | $0 | 77,338 (Direct) | View |
| 2025-07-02 Option Award | 2025-07-07 9:46 pm | 2026-07-02 2035-07-02 | Pelthos Therapeutics Inc. | PTHS | Greenleaf Peter Director | 103,118 | $0 | 103,118 (Direct) | View |
| 2025-07-02 Option Award | 2025-07-07 9:45 pm | 2026-07-02 2035-07-02 | Pelthos Therapeutics Inc. | PTHS | Pauls Matthew Director | 103,118 | $0 | 103,118 (Direct) | View |
| 2025-07-02 Option Award | 2025-07-07 9:44 pm | 2026-07-02 2035-07-02 | Pelthos Therapeutics Inc. | PTHS | Francis Knuettel II CFO, Treas & Secty | 135,472 | $0 | 178,546 (Direct) | View |
| 2025-07-02 Option Award | 2025-07-07 9:43 pm | 2026-07-02 2035-07-02 | Pelthos Therapeutics Inc. | PTHS | Davis Todd C Director | 77,338 | $0 | 95,199 (Direct) | View |
| 2025-07-02 Option Award | 2025-07-07 9:42 pm | 2026-07-02 2035-07-02 | Pelthos Therapeutics Inc. | PTHS | Friedberg Ezra M Director | 77,338 | $0 | 86,242 (Direct) | View |
| 2025-07-02 Option Award | 2025-07-07 9:41 pm | 2026-07-02 2035-07-02 | Pelthos Therapeutics Inc. | PTHS | Malamut Richard Director | 77,338 | $0 | 86,242 (Direct) | View |
| 2025-07-01 Conversion | 2025-07-03 9:05 pm | N/A N/A | Pelthos Therapeutics Inc. | PTHS | Friedberg Ezra M Director | 80,000 | $0 | 174,573 (Indirect) | View |
| 2025-07-01 Conversion | 2025-07-03 9:05 pm | N/A N/A | Pelthos Therapeutics Inc. | PTHS | Friedberg Ezra M Director | 40,000 | $10 | 174,573 (Indirect) | View |
| 2025-07-01 Conversion | 2025-07-03 9:04 pm | N/A N/A | Pelthos Therapeutics Inc. | PTHS | Francis Knuettel II Chief Financial Officer | 10,000 | $0 | 32,816 (Indirect) | View |
| 2025-07-01 Other | 2025-07-03 9:04 pm | N/A N/A | Pelthos Therapeutics Inc. | PTHS | Francis Knuettel II Chief Financial Officer | 10,000 | $0 | 32,816 (Indirect) | View |
| 2025-07-01 Conversion | 2025-07-03 9:04 pm | N/A N/A | Pelthos Therapeutics Inc. | PTHS | Francis Knuettel II Chief Financial Officer | 10,000 | $10 | 32,816 (Indirect) | View |